Search
01/11/2024
A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease
Ponce, MD, Schwieters, CFQ, Meziere, J, Curbelo, JRS, Carratala, GA, Troka, E, Arnau, LB, Castañé, ER, Barcina, MJM, Rajmil, O. A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216321. PMID:39518460. IF:2.900(Q1/2D).
01/11/2024
Burden of Mitral Regurgitation in Spain from 2016-2021: An Analysis by Aetiology and Sex
Zamorano, JL, Alvarez-Bartolomé, M, Arzamendi, D, Carnero-Alcázar, M, Cruz-González, I, Li, CHP, Pardo-Sanz, A, Martínez-Pérez, O, Cerezales, M, Cuervo, J, Vernia, M, González, P, Martí-Sánchez, B. Burden of Mitral Regurgitation in Spain from 2016-2021: An Analysis by Aetiology and Sex. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216372. PMID:39518512. IF:2.900(Q1/2D).
01/11/2024
Advances in the Assessment of Patients With Tricuspid Regurgitation: A State-of-the-Art Review on the Echocardiographic Evaluation Before and After Tricuspid Valve Interventions
Badano, LP, Tomaselli, M, Muraru, D, Galloo, X, Li, CHP, Marsan, NA. Advances in the Assessment of Patients With Tricuspid Regurgitation: A State-of-the-Art Review on the Echocardiographic Evaluation Before and After Tricuspid Valve Interventions. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY. 2024; 37(11)DOI:10.1016/j.echo.2024.07.008. PMID:39029717. IF:6.000(Q1/2D).
01/11/2024
Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology
González-Vílchez, F, Almenar-Bonet, L, Mitroi, C, Crespo-Leiro, MG, López-Granados, A, Valero, M, Delgado-Jiménez, JF, Mirabet-Pérez, S, Sobrino-Márquez, JM, García-Romeroo, E. Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(11)DOI:10.1016/j.rec.2024.05.015. PMID:39032818. IF:4.900(Q1/2D).
01/11/2024
Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)
Bastante, T, Arzamendi, D, Martín-Moreiras, J, Alvarez, ABC. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023). REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(11)DOI:10.1016/j.rec.2024.07.015. PMID:39332624. IF:4.900(Q1/2D).
01/11/2024
Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology
Teles, RC, Van Belle, E, Parma, R, Tarantini, G, Van Mieghem, N, Mylotte, D, Silva, JD, O'Connor, S, Sondegaard, L, Luz, A, Amat-Santos, IJ, Arzamendi, D, Blackman, D, De Backer, O, Kunadian, V, Buchanan, GL, MacCarthy, P, Lurz, P, Naber, C, Chieffo, A, Paradies, V, Gilard, M, Vincent, F, Fraccaro, C, Mehilli, J, Giannini, C, Silva, B, Poliacikova, P, Karam, N, Veulemans, V, Thiele, H, Pilgrim, T, van Wely, M, James, S, Schmidt, MR, Uebing, A, Rück, A, Ghanem, A, Ghazzal, Z, Joshi, FR, Favero, L, Hermanides, R, Ninios, V, Fovino, LN, Nuis, RJ, Deharo, P, Kala, P, Elbaz-Greener, G, Tchétché, D, Agricola, E, Thielmann, M, Donal, E, Bonaros, N, Droogmans, S, Czerny, M, Baumbach, A, Barbato, E, Dudek, D. Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology. EuroIntervention. 2024; 20(22)DOI:10.4244/EIJ-D-23-00983. PMID:39207816. IF:9.500(Q1/1D).
01/11/2024
Comparing Outcomes Between Advanced Practice Providers and Housestaff Teams in the Cardiac Intensive Care Unit.
Zhang RS, Zhang P, Bailey E, Ho A, Rhee A, Xia Y, Schimmer H, Bernard S, Castillo P, Grossman K, Dai M, Singh A, Padilla-Lopez M, Nunemacher K, Hall SF, Rosenzweig B, Katz JN, Link N, Keller N, Bangalore S, Alviar CL. Comparing Outcomes Between Advanced Practice Providers and Housestaff Teams in the Cardiac Intensive Care Unit.. JACC-ADVANCES. 2024; 3(11)DOI:10.1016/j.jacadv.2024.101312. PMID:39569031. IF:(Q/D).
01/11/2024
A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation
Sánchez-Quesada, JL. A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation. Clinica E Investigacion En Arteriosclerosis. 2024; 36(6)DOI:10.1016/j.arteri.2024.10.003. PMID:39542529. IF:(Q/D).
01/11/2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, AYY, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, MA, Bonnemaire, M, Melas-Melt, L, Mimouni, S, Davies, M. A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 217DOI:10.1016/j.diabres.2024.111871. PMID:39343145. IF:7.400(Q1/1D).
01/11/2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).
01/11/2024
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Gargallo-Puyuelo, CJ, Ricart, E, Iglesias, E, de Francisco, R, Gisbert, JP, Taxonera, C, Mañosa, M, Peris, MA, Navarrete-Muñoz, EM, Sanahuja, A, Guardiola, J, Mesonero, F, Tirado, MR, Barrio, J, Mendoza, IV, Parga, LD, García-Planella, E, Calvet, X, Arranz, MDM, García, S, Sicilia, B, Carpio, D, Domenech, E, Gomollón, F. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. Clinical Gastroenterology and Hepatology. 2024; 22(11)DOI:10.1016/j.cgh.2024.05.013. PMID:38782172. IF:12.000(Q1/1D).
01/11/2024
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
Martín-Gutiérrez, A, Loricera, J, Narváez, J, Aldasoro, V, Maiz, O, Vela, P, Romero-Yuste, S, de Miguel, E, Galíndez-Agirregoikoa, E, Fernández-López, JC, Ferraz-Amaro, I, Sánchez-Martín, J, Moya, P, Campos, C, Lopez-Gutierrez, F, Castaneda, S, Blanco, R. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 2024; 129DOI:10.1016/j.ejim.2024.06.013. PMID:38908981. IF:6.100(Q1/1D).
01/11/2024
Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice
Lopez-Gomez, M, Moya-Alvarado, P, Park, HS, Martín, MC, Calleja, S, Codes-Mendez, H, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Laiz, A, Diaz-Torné, C, Sainz, L, Bernárdez, J, Martínez-Martinez, L, Corominas, H. Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice. Diagnostics. 2024; 14(22)DOI:10.3390/diagnostics14222583. PMID:39594249. IF:3.300(Q1/2D).
01/11/2024
Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?
Codern, AR, Ruiz, VP, Mitjà, PS. Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(11)DOI:10.1016/j.arbres.2024.06.012. PMID:39013726. IF:9.200(Q1/1D).
01/11/2024
Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?
Arismendi, E, Ribo, P, Garcia, A, Torrego, A, Bobolea, I, Casas-Saucedo, R, Palomino, R, Picado, C, Muñoz-Cano, R, Valero, A. Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?. Journal of Clinical Medicine. 2024; 13(22)DOI:10.3390/jcm13226646. PMID:39597790. IF:2.900(Q1/2D).
01/11/2024
Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
Caballero-Borrego, M, Piedra, A, Gallego, O, López-Pousa, A, Castillo, P, Navarrete, P, Prat, A, Grau, JJ. Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Brazilian Journal of Otorhinolaryngology. 2024; 90(6)DOI:10.1016/j.bjorl.2024.101493. PMID:39205362. IF:1.800(Q2/4D).
01/11/2024
Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study
Krebs, MG, Forster, M, Majem, M, Peguero, J, Iams, W, Clay, T, Roxburgh, P, Doger, B, Bajaj, P, Barba, A, Perera, S, Mueller, C, Triebel, F. Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study. Jto Clinical And Research Reports. 2024; 5(11)DOI:10.1016/j.jtocrr.2024.100725. PMID:39403626. IF:(Q/D).
01/11/2024
Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial
Provencio, M, Nadal, E, Insa, A, Campelo, RG, Casal, J, Dómine, M, Massuti, B, Majem, M, Rodríguez-Abreu, D, Martínez-Marti, A, de Castro, J, de Antonio, DG, Macia, I, Figueroa, S, Vago, LF, Calvo, V, Palmero, R, Sierra-Rodero, B, Martínez-Toledo, C, Molina-Alejandre, M, Serna-Blasco, R, Romero, A, Cruz-Bermúdez, A. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial. LANCET ONCOLOGY. 2024; 25(11)DOI:10.1016/S1470-2045(24)00498-4. PMID:39419061. IF:35.900(Q1/1D).
01/11/2024
Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection
Borque-Fernando, A, Zapatero, A, Manneh, R, Alonso-Gordoa, T, Couñago, F, Domínguez-Esteban, M, López-Valcárcel, M, Rodríguez-Antolín, A, Sala-González, N, Sanmamed, N, Maroto, P. Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection. Actas Urologicas Espanolas. 2024; 48(9)DOI:10.1016/j.acuro.2024.03.002. PMID:38740263. IF:1.200(Q3/7D).
01/11/2024
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3
Gray, JE, Markovets, A, Reungwetwattana, T, Majem, M, Nogami, N, Peled, N, Lee, JS, Cho, BC, Chewaskulyong, B, John, T, Han, JY, Sebastian, M, Todd, A, Rukazenkov, Y, Barrett, C, Chmielecki, J, Lee, SM, Ramalingam, SS, Hartmaier, R. Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3. Journal of Thoracic Oncology. 2024; 19(11)DOI:10.1016/j.jtho.2024.07.008. PMID:39029876. IF:20.800(Q1/1D).